{ }
001122334455554433221100
001122334455554433221100
Symbol NVAX
Name Novavax, Inc.
Currency USD
Sector Health Care
IndustryGroup Pharmaceuticals, Biotechnology & Life Sciences
Industry Biotechnology
Market NASDAQ Global Select
Country United States
State MD
City Gaithersburg
Zipcode 20878
Website http://www.novavax.com

deutsche bank revises us auto sales forecast amid tariff concerns

Deutsche Bank has reduced its 2025 US light vehicle sales forecast by 500,000 to 15.4 million due to impending tariffs affecting auto supply chains and prices. Analysts predict a short-term sales boost as consumers rush to purchase before price hikes, but a significant decline is expected afterward.In the tech sector, Palantir's shares fell amid concerns over government spending cuts, while Moderna's stock dropped 10% following the resignation of the FDA's vaccine chief, raising questions about vaccine safety. Overall, US stocks faced a slump, particularly in consumer discretionary and tech sectors, as fears of an economic slowdown intensified.

vaccine producers face stock declines amid controversial health secretary nomination

Shares of major vaccine manufacturers, including Pfizer and Moderna, fell significantly after Robert F. Kennedy Jr. was nominated as Secretary of Health and Human Services by President-elect Donald Trump. Kennedy's controversial anti-vaccine stance has raised concerns about its potential impact on public health policies and the vaccine market, which has been crucial for pharmaceutical companies. His history of promoting unfounded vaccine theories could undermine public trust and affect future health initiatives.

health stocks plunge after trump appoints vaccine skeptic as health secretary

Health stocks have plummeted following Donald Trump's appointment of vaccine skeptic Robert F. Kennedy Jr. as health secretary, with Moderna, Pfizer, and GSK experiencing significant losses. The decline has affected US-exposed European healthcare stocks as well, amid growing uncertainty in the vaccine industry. Analysts have downgraded their outlooks on vaccine stocks, reflecting concerns over Kennedy's stance on vaccines and potential policy changes.

Trump nominates Kennedy Jr. as health secretary causing healthcare stocks to drop

Donald Trump's nomination of Robert F. Kennedy Jr. as Secretary of Health has led to a decline in healthcare stocks, with major companies like Pfizer and Moderna experiencing significant drops. Kennedy, known for his vaccine skepticism, could influence national health policies at a time when vaccination rates are falling, raising concerns among public health experts. The World Health Organization emphasized the critical role of vaccines in global health, highlighting the potential implications of Kennedy's appointment.

healthcare sector reacts negatively to robert f kennedy jr appointment

Robert F. Kennedy Jr.'s appointment as Health Minister in Donald Trump's administration has triggered a significant decline in pharmaceutical stocks across the US and Europe, with fears of potential drug price caps impacting investor confidence. Major companies like UCB and argenx saw sharp drops, reflecting broader concerns about the future of drug pricing and regulation under Kennedy's leadership. Analysts suggest that while there are constraints on his power, the potential for reduced regulations could lead to increased mergers and acquisitions in the sector.

vaccine maker stocks decline after trump nominates rfk jr for hhs

Shares of vaccine manufacturers plummeted following President-elect Donald Trump's nomination of Robert F. Kennedy Jr., a noted vaccine skeptic, to lead the Department of Health and Human Services. Moderna, Novavax, Pfizer, and BioNTech all experienced significant declines, with Moderna down over 5% and Novavax falling more than 7%. Experts warn that Kennedy's influence could amplify anti-vaccine sentiments, potentially hindering vaccination efforts in the U.S.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.